Crissman J - Search Results

1

"Histiocytic markers" in melanoma.

Pernick NL, DaSilva M, Gangi MD, Crissman J, Adsay V. Pernick NL, et al. Among authors: crissman j. Mod Pathol. 1999 Nov;12(11):1072-7. Mod Pathol. 1999. PMID: 10574605 Clinical Trial.

2

High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.

Grignon DJ, Sakr W, Toth M, Ravery V, Angulo J, Shamsa F, Pontes JE, Crissman JC, Fridman R. Grignon DJ, et al. Among authors: crissman jc. Cancer Res. 1996 Apr 1;56(7):1654-9. Cancer Res. 1996. PMID: 8603416

3

Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.

Visscher DW, Sarkar F, Tabaczka P, Crissman J. Visscher DW, et al. Among authors: crissman j. Mod Pathol. 1996 Jun;9(6):642-6. Mod Pathol. 1996. PMID: 8782201

4

Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast.

Visscher DW, Sarkar FH, Wykes S, Kothari K, Macoska J, Crissman J. Visscher DW, et al. Among authors: crissman j. Arch Pathol Lab Med. 1993 Oct;117(10):973-6. Arch Pathol Lab Med. 1993. PMID: 8215837

5

Immunohistologic analysis of invasive phenotype in breast carcinoma. A clinicopathologic study.

Visscher DW, Sarkar FH, Sakr W, Crissman J. Visscher DW, et al. Among authors: crissman j. Pathol Res Pract. 1993 Sep;189(8):867-72. doi: 10.1016/S0344-0338(11)81096-4. Pathol Res Pract. 1993. PMID: 8302708

6

Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant.

Adsay V, Logani S, Sarkar F, Crissman J, Vaitkevicius V. Adsay V, et al. Among authors: crissman j. Am J Surg Pathol. 2000 Apr;24(4):493-504. doi: 10.1097/00000478-200004000-00003. Am J Surg Pathol. 2000. PMID: 10757396

7

Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer.

Ravery V, Grignon D, Angulo J, Pontes E, Montie J, Crissman J, Chopin D. Ravery V, et al. Among authors: crissman j. Urol Res. 1997;25(1):9-17. doi: 10.1007/BF00941900. Urol Res. 1997. PMID: 9079740

8

Solid tumor preparation for clinical application of flow cytometry.

Ensley JF, Maciorowski Z, Pietraszkiewicz H, Hassan M, Kish J, Al-Sarraf M, Jacobs J, Weaver A, Atkinson D, Crissman J. Ensley JF, et al. Among authors: crissman j. Cytometry. 1987 Sep;8(5):488-93. doi: 10.1002/cyto.990080509. Cytometry. 1987. PMID: 3665673

9

Recommendations for the reporting of larynx specimens containing laryngeal neoplasms.

Gnepp DR, Barnes L, Crissman J, Zarbo R. Gnepp DR, et al. Among authors: crissman j. Am J Clin Pathol. 1998 Aug;110(2):137-9. doi: 10.1093/ajcp/110.2.137. Am J Clin Pathol. 1998. PMID: 9704610 No abstract available.

10

Geographic distribution of co-dominant DNA stemlines in breast carcinoma.

Visscher D, Dolan P, Ottosen S, Crissman J. Visscher D, et al. Among authors: crissman j. Cytometry. 1995 Sep 1;21(1):14-7. doi: 10.1002/cyto.990210105. Cytometry. 1995. PMID: 8529464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results